Nifty
:
23416.55
Sensex
:
74360.01
10.95 (0.05%)
13.84 (0.02%)
Nifty
Sensex
:
:
23416.55
74360.01
10.95 (0.05%)
13.84 (0.02%)

Sakar Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :
72/99

BSE: Not Listed | NSE: SAKAR

NSE BSE
814.85
04-Jun-2026
  • Open
  • High
  • Low
  • Previous Close
  •  812.85
  •  827
  •  812
  •  812.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  45791
  •  37563228.9
  •  871.3
  •  306.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,813.03
  • 59.47
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,868.08
  • N/A
  • 5.59

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 52.86%
  • 3.24%
  • 18.12%
  • FII
  • DII
  • Others
  • 12.94%
  • 0.00%
  • 12.84%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.72
  • 13.39
  • 10.02

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.61
  • 17.06
  • 8.36

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.34
  • 10.38
  • 11.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 40.98
  • 51.57

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 2.78
  • 2.95

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 16.58
  • 18.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
71.10
50.24
41.52%
70.34
43.42
62.00%
57.56
42.78
34.55%
52.74
41.15
28.17%
Expenses
44.86
34.52
29.95%
51.75
31.66
63.46%
46.21
31.28
47.73%
40.03
30.45
31.46%
EBITDA
26.24
15.73
66.82%
18.59
11.76
58.08%
11.35
11.50
-1.30%
12.71
10.70
18.79%
EBIDTM
36.90%
31.30%
26.43%
27.08%
19.73%
26.89%
24.09%
26.00%
Other Income
0.17
0.18
-5.56%
0.51
0.30
70.00%
1.22
0.37
229.73%
0.39
0.46
-15.22%
Interest
2.41
4.19
-42.48%
1.77
1.30
36.15%
1.53
1.64
-6.71%
2.14
1.40
52.86%
Depreciation
5.94
5.48
8.39%
6.37
5.23
21.80%
5.68
5.12
10.94%
5.57
5.06
10.08%
PBT
18.06
6.24
189.42%
10.95
5.48
99.82%
5.36
5.11
4.89%
5.38
4.70
14.47%
Tax
7.03
0.48
1,364.58%
0.70
0.94
-25.53%
0.82
0.32
156.25%
0.71
2.29
-69.00%
PAT
11.03
5.76
91.49%
10.25
4.53
126.27%
4.54
4.80
-5.42%
4.67
2.41
93.78%
PATM
15.51%
11.47%
14.57%
10.44%
7.89%
11.21%
8.86%
5.86%
EPS
4.95
2.62
88.93%
4.61
2.07
122.71%
2.04
2.21
-7.69%
2.10
1.11
89.19%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
251.74
177.58
153.35
133.36
128.23
94.74
82.98
Net Sales Growth
41.75%
15.80%
14.99%
4.00%
35.35%
14.17%
 
Cost Of Goods Sold
123.28
82.27
83.67
73.54
74.42
51.11
43.05
Gross Profit
128.46
95.32
69.67
59.81
53.80
43.63
39.93
GP Margin
51.03%
53.68%
45.43%
44.85%
41.96%
46.05%
48.12%
Total Expenditure
182.85
127.88
114.96
100.09
98.89
72.13
63.43
Power & Fuel Cost
-
5.15
4.25
2.90
3.01
2.26
3.31
% Of Sales
-
2.90%
2.77%
2.17%
2.35%
2.39%
3.99%
Employee Cost
-
30.15
18.82
15.81
14.26
12.74
11.61
% Of Sales
-
16.98%
12.27%
11.86%
11.12%
13.45%
13.99%
Manufacturing Exp.
-
0.83
1.34
0.81
1.24
1.20
1.64
% Of Sales
-
0.47%
0.87%
0.61%
0.97%
1.27%
1.98%
General & Admin Exp.
-
5.40
4.22
3.65
3.43
2.87
2.68
% Of Sales
-
3.04%
2.75%
2.74%
2.67%
3.03%
3.23%
Selling & Distn. Exp.
-
3.26
2.17
3.06
2.38
1.33
1.10
% Of Sales
-
1.84%
1.42%
2.29%
1.86%
1.40%
1.33%
Miscellaneous Exp.
-
0.83
0.49
0.32
0.15
0.61
0.04
% Of Sales
-
0.47%
0.32%
0.24%
0.12%
0.64%
0.05%
EBITDA
68.89
49.70
38.39
33.27
29.34
22.61
19.55
EBITDA Margin
27.37%
27.99%
25.03%
24.95%
22.88%
23.87%
23.56%
Other Income
2.29
1.31
3.18
4.67
2.17
1.18
2.02
Interest
7.85
8.55
7.62
5.96
2.91
2.49
2.26
Depreciation
23.56
20.88
18.05
14.99
9.67
8.06
7.08
PBT
39.75
21.58
15.90
16.99
18.93
13.23
12.23
Tax
9.26
4.03
4.23
4.23
3.75
2.55
2.60
Tax Rate
23.30%
18.72%
26.60%
24.90%
19.81%
19.27%
21.26%
PAT
30.49
17.50
11.67
12.76
15.18
10.68
9.62
PAT before Minority Interest
30.49
17.50
11.67
12.76
15.18
10.68
9.62
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
12.11%
9.85%
7.61%
9.57%
11.84%
11.27%
11.59%
PAT Growth
74.23%
49.96%
-8.54%
-15.94%
42.13%
11.02%
 
EPS
13.73
7.88
5.26
5.75
6.84
4.81
4.33

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
285.48
262.33
173.35
127.45
98.45
81.32
Share Capital
21.95
21.75
19.04
17.12
15.62
14.96
Total Reserves
260.65
235.78
154.31
110.33
82.83
66.36
Non-Current Liabilities
66.60
67.27
108.50
93.54
46.07
19.57
Secured Loans
53.58
52.30
93.17
79.93
35.04
8.79
Unsecured Loans
0.01
2.65
5.05
5.07
3.41
3.68
Long Term Provisions
2.66
2.29
1.70
1.44
0.79
0.70
Current Liabilities
63.19
59.06
54.49
46.78
33.27
14.15
Trade Payables
21.07
27.45
26.09
30.50
19.78
5.44
Other Current Liabilities
19.43
16.30
13.58
8.57
8.82
4.98
Short Term Borrowings
21.36
13.88
13.02
4.52
1.69
2.18
Short Term Provisions
1.33
1.43
1.80
3.19
2.97
1.55
Total Liabilities
415.27
388.66
336.34
267.77
177.79
115.04
Net Block
308.96
314.29
266.64
204.65
69.10
65.69
Gross Block
386.10
370.69
304.99
235.50
90.28
78.81
Accumulated Depreciation
77.14
56.40
38.35
30.84
21.18
13.12
Non Current Assets
326.53
317.05
280.42
217.74
144.07
93.46
Capital Work in Progress
16.70
0.32
6.45
1.23
48.92
13.10
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
0.87
2.44
7.33
11.86
26.05
14.68
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
88.73
71.61
55.92
50.02
33.72
21.58
Current Investments
0.00
0.00
3.43
7.11
0.00
0.00
Inventories
43.59
27.73
15.40
14.18
15.70
10.93
Sundry Debtors
30.72
20.91
22.08
14.18
12.37
8.23
Cash & Bank
0.31
0.47
0.09
0.03
0.08
0.30
Other Current Assets
14.10
0.85
0.46
0.22
5.57
2.12
Short Term Loans & Adv.
13.76
21.65
14.46
14.30
5.48
2.04
Net Current Assets
25.54
12.55
1.42
3.25
0.45
7.42
Total Assets
415.26
388.66
336.34
267.76
177.79
115.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
34.03
24.47
33.34
35.70
14.58
18.86
PBT
21.53
15.90
16.88
18.93
13.23
12.23
Adjustment
28.96
24.90
20.14
12.50
8.90
9.19
Changes in Working Capital
-14.08
-13.18
0.60
4.09
-6.83
0.22
Cash after chg. in Working capital
36.41
27.62
37.61
35.52
15.30
21.64
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.37
-3.15
-4.27
0.18
-0.73
-2.77
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-30.71
-51.54
-74.38
-90.37
-46.83
-22.41
Net Fixed Assets
-31.79
-59.57
-74.71
-97.53
-47.29
Net Investments
0.00
3.43
3.68
-7.11
0.00
Others
1.08
4.60
-3.35
14.27
0.46
Cash from Financing Activity
-3.48
27.44
41.10
54.62
32.03
3.48
Net Cash Inflow / Outflow
-0.16
0.37
0.06
-0.05
-0.22
-0.06
Opening Cash & Equivalents
0.47
0.09
0.03
0.08
0.31
0.37
Closing Cash & Equivalent
0.31
0.47
0.09
0.03
0.08
0.31

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
128.75
118.41
91.04
74.45
63.04
54.35
ROA
4.35%
3.22%
4.22%
6.81%
7.30%
8.36%
ROE
6.48%
5.42%
8.48%
13.44%
11.88%
11.83%
ROCE
8.43%
7.42%
8.95%
12.09%
13.16%
14.79%
Fixed Asset Turnover
0.47
0.45
0.49
0.79
1.12
1.05
Receivable days
53.06
51.16
49.62
37.80
39.70
36.22
Inventory Days
73.30
51.33
40.48
42.53
51.30
48.09
Payable days
107.64
116.77
140.43
123.30
90.05
46.13
Cash Conversion Cycle
18.72
-14.29
-50.33
-42.97
0.95
38.18
Total Debt/Equity
0.31
0.31
0.69
0.73
0.43
0.20
Interest Cover
3.52
3.09
3.85
7.51
6.30
6.41

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Sakar Healthcare - Quarterly Results
    13th May 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.